根据 位华尔街分析师的预测,Cbd Life Sciences Inc 的收入预期范围从 $ 到 $
Cbd Life Sciences Inc 的盈利质量评分是多少?
Cbd Life Sciences Inc 的盈利质量评分为 /。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
Cbd Life Sciences Inc 何时发布财报?
Cbd Life Sciences Inc 的下一份财报预计在 发布
Cbd Life Sciences Inc 的预期收益是多少?
根据华尔街分析师的预测,Cbd Life Sciences Inc 的预期收益为 $
Cbd Life Sciences Inc 是否超出收益预期?
Cbd Life Sciences Inc 最近的收益为 $, 预期。
关键数据
前收盘价
$0.0002
开盘价
$0.0001
当日区间
$0.0001 - $0.0001
52周范围
$0.0001 - $0.001
交易量
188.6K
平均成交量
9.8M
股息收益率
--
每股收益(TTM)
--
市值
$2.4M
什么是 CBDL?
CBD Life Sciences, Inc. focuses on identifying, evaluating and acquiring undervalued opportunities with the objective of increasing shareholder value. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2013-08-12. Its discovery and reporting process designed for the health care industry. The firm is focused on hospitals, nursing homes and doctor’s offices. The firm assists in protecting these organizations in protecting from cyber threats, such as the theft of patient medical records and manipulation of medical devices.